Posts Tagged ‘leprosy’

Four NTD successes you should know about

September 8th, 2011

By: Alanna Shaikh

I don’t know about you, but I’ve found world news to be pretty depressing this week. It seemed like a good time to remind ourselves that things do improve, and we can change global health for the better. I therefore offer you four NTD success stories:

1.       Guinea Worm, aka Dracunculiasis, is on the verge of being eradicated. It is, as you may recall, one of the most wiggly and revolting NTDs, consisting of a giant worm that lives inside you and has to be removed manually and with excruciating slowness. And we’re going to make it the third disease ever to be eradicated.[1] We’ve gone from 3.5 million cases of guinea worm in 1986 to under 5000 in 2009. How awesome is that?[2]

2.       Leprosy is being reduced in a big way. 14.5 million people have been cured of leprosy since 1985. (Yes, cured. Leprosy is a bacterial infection and doesn’t stand a chance against strong antibiotics.) It’s now a problem in only seven countries. [3] It’s a disease to old — it was mentioned in the Bible, and we’re getting rid of it most likely within our lifetime.

3.       China eliminated lymphatic filariasis in 2007. Also known as elephantiasis, lymphatic filariasis makes your limbs swell up to enormous proportions. It causes intense pain, and, obviously, disfigurement. And now it’s gone from China. Boom![4]

4.       2007 was a good year for NTDs.[5] It also saw the elimination of onchocerciasis in Colombia. It was the result of effective action from the government of Colombia and donations of ivermectin from twice-annual mass drug administration of ivermectin to people at risk for the disease. The program became a model for Latin American and was an example of mass drug administration as an effective approach to eliminating onchocerciasis. It’s been copied all over the world.

Insofar as there is a bright side to NTDs, this is it: we can fight them and win. We’ve done it before, and we’ll do it again.


[1] You’re thinking it will be the second disease to be eradicated, aren’t you? Well, you’re forgetting rinderpest. Sure, rinderpest isn’t a human disease, but I think we can agree it’s a good thing if cattle don’t get diarrhea, oral erosions, and necrosis and then die.

[2]Harshing the vibe somewhat – slightly less awesomely, this had to be achieved through changing human behavior because we still don’t have any really effective treatments for Guinea Worm disease. We’ll keep that down here in the fine print so we don’t ruin the happy. And when you consider it, behavior change on that level is pretty awesome too.

[3] For the record, leprosy does not actually cause limbs to fall off, although it can make them numb. We’re not talking zombies here.

[4] Yeah, I don’t know. Boom just seemed like a happy thing to write. The actually eradication process took years of diligent effort and was not boom-like at all. There is almost no boom in global health.

[5] Well, a bad year for the diseases; a good year for the people who might get them.

Alanna Shaikh is an expert in health consulting, writing about global health for UN Dispatch and about international relief and development at Blood & Milk. She also serves as a frequently contributing blogger to ‘End the Neglect.’ The views and opinions expressed by guest bloggers are not necessarily the views and opinions of the Global Network. All opinions expressed here are Alanna’s own and not those of any employer or the US government.

Leprosy, Possibly the Most Annoying NTD

March 2nd, 2011

By: Alanna Shaikh

Here’s the thing about leprosy. It’s totally, completely, absolutely treatable; World Health Organization (WHO) provides free drugs to make treatment even easier. Leprosy progresses slowly – like 20 years slowly and it is not infectious. So what the heck? Why can’t we just eliminate leprosy already? Why do people still get this disease? Why does it go untreated long enough that we still see pictures like this?

WHO pronounced the elimination of leprosy as no longer a public health threat, in 2000. That means that the disease has a prevalence of less than one case per 10,000 people[1], largely because multi-drug therapy for leprosy is really effective. (And, as I previously mentioned, free as the result of donations from Novartis and the Novartis Foundation for Sustainable Development.)

But “not a public health threat” doesn’t mean “gone”. The 2008 disease burden for leprosy was 213,086 cases. Not a big number, I admit, but not zero. I want zero. Why can’t we have zero?

The reasons we are not at zero are, of course, depressingly familiar.  Though the drugs to treat leprosy are free, transportation and administration costs are not. You need a functional health system to diagnose leprosy, start patients on treatment, and make sure that they are able to finish their treatment.

» Read more: Leprosy, Possibly the Most Annoying NTD

Integrated Programs for Disability Prevention

August 10th, 2010

By: LEPRA Health In Action

Washing is an important self care technique to prevent and treat LF and Leprosy patients. Photo Credit: LEPRA Health in Action

According to The World Health Organization a ‘fundamental prerequisite for accelerating the elimination of lymphatic filariasis, is the integration of the programme with other disease control/eradication programmes’. Disability prevention is however an essential part of LF elimination.  

Where people are already affected by the mosquito borne disease LEPRA Health in Action has found that an integrated approach using self-care techniques to treat patients with LF along with leprosy and other lower limb disabilities is reaping rewards.

In places like Bangladesh and northern India there are few specialist services to help disabled people and government health centres are often only able to offer primary health care. The result is that preventable disability can occur. In addition to the physical effects of these diseases patients’ self-esteem and economic well-being can also be affected. » Read more: Integrated Programs for Disability Prevention

New Scientific Paper Examines the Lack of Scientific Interest in Neglected Tropical Diseases

February 3rd, 2010

As part of the global health community, we are always working to raise the profile of the neglected tropical diseases. 

A paper  released in the January 26th, 2010 edition of the online peer-reviewed scientific journal PLoS Neglected Tropical Diseases, looks at the lack of research and attention given to the NTDs.  Author Dieter Vanderelst,an economist at the University of Antwerp, argues that scientific research into the NTDs lags behind other diseases which have a similar burden around the world. Not only does this disparity exist, but it is likely underestimated.

The researchers write that, “The disproportionally low research interest in NTDs is doubly worrying if one considers that the DALYs associated with NTDs are generally assumed to be underestimated.” DALYs are a public health measurement that takes into account the years of life a person loses due to either illness or death from a specific disease. Although there has been measurable growth in the body of research around the NTDs, this has been largely attributed to the creation of the NTD specific PloS journal.

Similarly, resources for NTDs are growing due to the increased interest in global health and now many new partners are working on cost effective and efficient solutions and interventions.  “It will be necessary for civil society, scientists, and policymakers alike to break this cycle so that some of the most common infections among the 2.7 billion people living on less than US$ 2 per day receive the attention they deserve.” Although progress is being made, there is still a lot of work to be done.

With the release of President Obama’s proposed FY11 budget allocating $155 million towards NTD control and elimination efforts it seems as if the Administration is making NTDs a significant priority. In particular, the Administration is seeking to reduce the prevalence of NTDs globally by 50% within 70% of all of the affected population, eliminate onchocerciasis in Latin America by 2016, eliminate lymphatic filariasis globally by 2017, and eliminate leprosy globally. With this new focus on NTDs, and the associated increase in resources, perhaps the research gap for NTDs will begin to close.